V030-7018 Screening compound: 4-(5-methyl-1,3-benzoxazol-2-yl)-2-[(morpholin-4-yl)methyl]phenyl 2-(trifluoromethoxy)benzene-1-sulfonate

V030-7018 Screening compound: 4-(5-methyl-1,3-benzoxazol-2-yl)-2-[(morpholin-4-yl)methyl]phenyl 2-(trifluoromethoxy)benzene-1-sulfonate
V030-7018 Screening compound: 4-(5-methyl-1,3-benzoxazol-2-yl)-2-[(morpholin-4-yl)methyl]phenyl 2-(trifluoromethoxy)benzene-1-sulfonate alternative view

Chemical Structure Depiction of ChemDiv screening compound V030-7018
4-(5-methyl-1,3-benzoxazol-2-yl)-2-[(morpholin-4-yl)methyl]phenyl 2-(trifluoromethoxy)benzene-1-sulfonate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V030-7018

Molecular Formula

C26H23F3N2O6S (C26 H23 F3 N2 O6 S)

Compound Name

4-(5-methyl-1,3-benzoxazol-2-yl)-2-[(morpholin-4-yl)methyl]phenyl 2-(trifluoromethoxy)benzene-1-sulfonate

IUPAC name

4-(5-methyl-13-benzoxazol-2-yl)-2-[(morpholin-4-yl)methyl]phenyl 2-(trifluoromethoxy)benzene-1-sulfonate

SMILES

Cc(cc1)cc2c1oc(-c(cc1)cc(CN3CCOCC3)c1OS(c(cccc1)c1OC(F)(F)F)(=O)=O)n2

InChI

InChI=1S/C26H23F3N2O6S/c1-17-6-8-22-20(14-17)30-25(35-22)18-7-9-21(19(15-18)16-31-10-12-34-13-11-31)37-38(32,33)24-5-3-2-4-23(24)36-26(27,28)29/h2-9,14-15H,10-13,16H2,1H3

InChI Key

MMWGDGPTCPXSBS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19794855

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

548.54

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.342

Distribution Coefficient, logD

5.341

Water Solubility, LogSw

-5.44

Polar Surface Area

70.561

Acid Dissociation Constant (pKa)

28.01

Base Dissociation Constant (pKb)

4.31

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.90

V030-7018 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with V030-7018 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V030-7018?
Check Price and Availability of V030-7018, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V030-7018 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V030-7018
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V030-7018
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V030-7018 available by request